SCHEMBL33331

SCHEMBL33331

C=C(C)C(=O)ONC(Cc1ccc(O)cc1)C(=O)O

nearest known ligand 0.49

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
FOLH1 Q04609 1/20 0.49
SLC7A5 Q01650 1/20 0.46
NAALAD2 Q9Y3Q0 1/20 0.46
MME P08473 6/20 0.45
ACE P12821 6/20 0.45
CPA1 P15085 1/20 0.45
ACE2 Q9BYF1 1/20 0.45
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
ESR1 P03372 2/20 0.41
ESR2 Q92731 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL33332 1.00 FOLH1 (0.49) FOLH1SLC7A5NAALAD2MMEACE
SCHEMBL33446 0.89 FPR2 (0.47) SLC7A5NAALAD2MMEACECPA1
SCHEMBL33445 0.89 FPR2 (0.47) SLC7A5NAALAD2MMEACECPA1
SCHEMBL6522472 0.86 SLC7A5 (0.49) FOLH1SLC7A5MMEACECPA1
SCHEMBL5843022 0.84 ITGB3 (0.43) MMEACECPA1ACE2KMT2A
SCHEMBL11035787 0.84 ITGB3 (0.43) MMEACECPA1ACE2KMT2A
SCHEMBL5841271 0.81 FOLH1 (0.49) FOLH1SLC7A5NAALAD2MMEACE
SCHEMBL22361655 0.80 FOLH1 (0.51) FOLH1SLC7A5NAALAD2MMEACE
SCHEMBL476061 0.79 FOLH1 (0.56) FOLH1SLC7A5NAALAD2MMEACE
SCHEMBL476060 0.79 FOLH1 (0.56) FOLH1SLC7A5NAALAD2MMEACE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1973587-A2 METHODS AND SYSTEMS FOR PREPARING ANTIMICROBIAL FILMS AND COATINGS Allaccem, Inc. (US) 2008-10-01 EP claimed
WO-2007070801-A2 METHODS AND SYSTEMS FOR PREPARING ANTIMICROBIAL FILMS AND COATINGS ALLACCEM, INC. (US) 2007-06-21 WO claimed
US-7226960-B2 Self-etching primer adhesive and method of use therefor PENTRON CLINICAL TECHNOLOGIES, LLC (US) 2007-06-05 US claimed
US-7115674-B2 Dental self-curing resin cement compositions DENTKIST, INC. (KR) 2006-10-03 US claimed
US-20050049326-A1 Dental self-curing resin cement compositions DENTKIST, INC. (KR) 2005-03-03 US claimed
US-20030207960-A1 Self-etching primer adhesive and method of use therefor PENTRON CLINICAL TECHNOLOGIES, LLC 2003-11-06 US claimed
US-6326417-B1 CONTAINING SALICYLIC ACID COMPOUND AS MICROBIOCIDES JENERIC/PENTRON INCORPORATED 2001-12-04 US claimed
US-20250382506-A1 SHELF STABLE ADHESIVE COMPOSITIONS UNIV KANSAS (US) 2025-12-18 US disclosed
US-20250340760-A1 ADHESIVE COMPOSITIONS CONTAINING MAGNETIC PARTICLES UNIV KANSAS (US) 2025-11-06 US disclosed
US-12351745-B2 Single-component adhesive compositions OHIO STATE INNOVATION FOUNDATION (US) 2025-07-08 US disclosed
EP-4547771-A1 SHELF STABLE ADHESIVE COMPOSITIONS University of Kansas (US) 2025-05-07 EP disclosed
EP-4547770-A1 ADHESIVE COMPOSITIONS CONTAINING MAGNETIC PARTICLES University of Kansas (US) 2025-05-07 EP disclosed
WO-2024006425-A1 ADHESIVE COMPOSITIONS CONTAINING MAGNETIC PARTICLES UNIVERSITY OF KANSAS (US) 2024-01-04 WO disclosed
US-7115674-B2 Dental self-curing resin cement compositions DENTKIST, INC. (KR) 2006-10-03 US disclosed
US-20050049326-A1 Dental self-curing resin cement compositions DENTKIST, INC. (KR) 2005-03-03 US disclosed
US-20030207960-A1 Self-etching primer adhesive and method of use therefor PENTRON CLINICAL TECHNOLOGIES, LLC 2003-11-06 US disclosed
US-20020045678-A1 Dental restorative compositions and method of use thereof JENERIC/PENTRON INCORPORATED 2002-04-18 US disclosed
WO-2002015848-A2 DENTAL RESTORATIVE COMPOSITIONS AND METHOD OF USE THEREOF JENERIC/PENTRON INCORPORATED (US) 2002-02-28 WO disclosed
US-6326417-B1 CONTAINING SALICYLIC ACID COMPOUND AS MICROBIOCIDES JENERIC/PENTRON INCORPORATED 2001-12-04 US disclosed
US-5264513-A Dental adhesive KABUSHIKI KAISHA SHOFU (JP) 1993-11-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250340760-A1 ADHESIVE COMPOSITIONS CONTAINING MAGNETIC PARTICLES FN1, EPCAM, VCL FOLH1 1253/4885SLC7A5 4452/4885NAALAD2 2753/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.